[1]
Witek , P., Mazur , M. and Witek , J. 2017. Cushing’s disease: is pasireotide LAR a breakthrough in adjuvant therapy after unsuccessful surgery?. OncoReview. 7, 4(28) (Dec. 2017), 176-179. DOI:https://doi.org/10.24292/01.OR.211217.